Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Sirolimus outperforms alpelisib in models of NRAS Q61R -driven vascular overgrowth.
Journal: Blood vessels, thrombosis & hemostasis
Published: April 27, 2026
RAS Inhibitor RMC-7977 Blocks Vascular Overgrowth of NRASQ61R Mutant Endothelial Cells.
Journal: Journal of cellular and molecular medicine
Published: April 18, 2026
Trametinib normalizes angiopoietin-2 levels and successfully treats kaposiform lymphangiomatosis.
Journal: Journal of vascular anomalies
Published: March 06, 2026
Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus.
Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus.
Journal: Pediatric blood & cancer
Published: December 17, 2025
MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in NRASQ61R Human Endothelial Cells.
Journal: Pediatric blood & cancer
Published: August 13, 2025
MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in NRASQ61R Human Endothelial Cells.
Journal: Pediatric blood & cancer
Published: August 13, 2025
Major Adverse Events With Chimeric Antigen Receptor T-Cell Therapy: Presentation, Diagnosis, and Resuscitation.
Journal: Annals of emergency medicine
Published: March 19, 2025
RAS Pathway Mutations and Therapeutics in Vascular Anomalies.
Journal: Pediatric blood & cancer
Published: November 14, 2024
Unusual foreign body aspiration in a 4-year-old patient.
Journal: Journal of the American College of Emergency Physicians open
Published: April 29, 2024
Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation.
Journal: Transplantation and cellular therapy
Published: March 28, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026